OBJECTIVES: Although usually mild, 2009 H1N1 Influenza has caused up to 6000 deaths in the US. To determine outcome in patients with cancer and/or hematopoietic stem cell transplant (HSCT), we reviewed our recent experience at Memorial Sloan-Kettering Cancer Center (MSKCC). METHODS: During the initial NYC outbreak (May 19-June 30, 2009), all respiratory samples at MSKCC were tested for 2009 H1N1 influenza by DFA, culture, and RT-PCR. Medical records were reviewed for all cases. RESULTS: During the 6-week period, 45(11%) of 394 tested patients were diagnosed with 2009 H1N1 Influenza. These included 29(17%) of 167 patients with hematologic conditions compared to 16(7%) of 226 with solid tumors (P < 0.01). 21(22%) of 96 tested HSCT recipients were positive. Cough (93%) and fever (91%) were common. Of 29 patients who were radiographically assessed, 8(27%) had lower airway disease. 17(37%) were hospitalized. None required mechanical ventilation. No deaths were attributed to influenza. All treated patients tolerated antiviral medication. CONCLUSIONS: 2009 H1N1 Influenza caused mild symptoms in most patients with cancer and/or HSCT. None died or required mechanical ventilation. Immunosuppression from cancer or its treatment including HSCT may not be a substantial risk for poor outcome, however further studies are needed to validate our results. Copyright 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
OBJECTIVES: Although usually mild, 2009 H1N1 Influenza has caused up to 6000 deaths in the US. To determine outcome in patients with cancer and/or hematopoietic stem cell transplant (HSCT), we reviewed our recent experience at Memorial Sloan-Kettering Cancer Center (MSKCC). METHODS: During the initial NYC outbreak (May 19-June 30, 2009), all respiratory samples at MSKCC were tested for 2009 H1N1 influenza by DFA, culture, and RT-PCR. Medical records were reviewed for all cases. RESULTS: During the 6-week period, 45(11%) of 394 tested patients were diagnosed with 2009 H1N1 Influenza. These included 29(17%) of 167 patients with hematologic conditions compared to 16(7%) of 226 with solid tumors (P < 0.01). 21(22%) of 96 tested HSCT recipients were positive. Cough (93%) and fever (91%) were common. Of 29 patients who were radiographically assessed, 8(27%) had lower airway disease. 17(37%) were hospitalized. None required mechanical ventilation. No deaths were attributed to influenza. All treated patients tolerated antiviral medication. CONCLUSIONS: 2009 H1N1 Influenza caused mild symptoms in most patients with cancer and/or HSCT. None died or required mechanical ventilation. Immunosuppression from cancer or its treatment including HSCT may not be a substantial risk for poor outcome, however further studies are needed to validate our results. Copyright 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
Authors: Luke F Chen; Natalie J M Dailey; Agam K Rao; Aaron T Fleischauer; Ian Greenwald; Varough M Deyde; Zack S Moore; Deverick J Anderson; Jonathan Duffy; Larisa V Gubareva; Daniel J Sexton; Alicia M Fry; Arjun Srinivasan; Cameron R Wolfe Journal: J Infect Dis Date: 2011-03-15 Impact factor: 5.226
Authors: Charles R Beck; Rachel Sokal; Nachiappan Arunachalam; Richard Puleston; Anna Cichowska; Anthony Kessel; Maria Zambon; Jonathan S Nguyen-Van-Tam Journal: Influenza Other Respir Viruses Date: 2013-01 Impact factor: 4.380
Authors: Su-Mi Choi; Alexandre A Boudreault; Hu Xie; Janet A Englund; Lawrence Corey; Michael Boeckh Journal: Blood Date: 2011-03-03 Impact factor: 22.113
Authors: Nicolas C Issa; Francisco M Marty; Lisa S Gagne; Sophia Koo; Kelly A Verrill; Edwin P Alyea; Corey S Cutler; John Koreth; Philippe Armand; Vincent T Ho; Joseph H Antin; Robert J Soiffer; Lindsey R Baden Journal: Biol Blood Marrow Transplant Date: 2010-10-13 Impact factor: 5.742
Authors: C Renaud; S A Pergam; C Polyak; R Jain; J Kuypers; J A Englund; L Corey; M J Boeckh Journal: Transpl Infect Dis Date: 2010-11-10 Impact factor: 2.228
Authors: Thiago Moreno L Souza; Jorge I F Salluh; Fernando A Bozza; Milene Mesquita; Márcio Soares; Fernando C Motta; Melissa Tassano Pitrowsky; Maria de Lourdes Oliveira; Vasiliy P Mishin; Larissa V Gubareva; Anne Whitney; Sandra Amaral Rocco; Vânia Maria C Gonçalves; Venceslaine Prado Marques; Eduardo Velasco; Marilda M Siqueira Journal: PLoS One Date: 2010-11-30 Impact factor: 3.240